Walking With AMPYRA:
AMPYRA® (dalfampridine) is the only FDA-approved medication shown to improve walking in people with MS. AMPYRA improved walking in significantly more people than placebo (sugar pill) in two clinical trials (34.8% vs. 8.3% and 42.9% vs. 9.3%). Not everyone responds to AMPYRA. Individual results may vary.
See real patient videos, before and after AMPYRA
These videos show real people with multiple sclerosis (MS) who were prescribed AMPYRA. The videos were recorded during healthcare provider office visits.
Patients in these videos had varying responses to AMPYRA. It is important to note that not everyone will respond to AMPYRA. Individual results may vary.
What might a possible response to AMPYRA look like?
|Standard Walking Test: TIMED 25-FT WALK||NOT taking AMPYRA* (Left side of video)||Taking AMPYRA (Right side of video)|
|Time it took to walk towards the camera||12.15 sec||7.12 sec|
|Speed||2.06 feet/sec||3.51 feet/sec|
|Time it took to walk away from the camera||11.75 sec||6.84 sec|
|Speed||2.13 feet/sec||3.65 feet/sec|
*Treatment stopped for ≥72 hours
|Standard Walking Test: 2-MINUTE TIMED WALK||NOT taking AMPYRA* (Left side of video)||Taking AMPYRA (Right side of video)|
|Distance covered||195 feet||315 feet|
|Speed||1.63 feet/sec||2.63 feet/sec|
*Treatment stopped for ≥48 hours
About this video:
This video shows an actual patient with MS who was prescribed AMPYRA. The patient shown in this video performed a timed 25-foot walk and a timed 2-minute walk, shown side by side both on and off AMPYRA. The video was recorded during a healthcare provider office visit.